We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+11.05%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.53B
AUM Growth
-$150M
Cap. Flow
-$510M
Cap. Flow %
-11.27%
Top 10 Hldgs %
8.72%
Holding
765
New
71
Increased
198
Reduced
404
Closed
78

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.4M
2
EW icon
Edwards Lifesciences
EW
+$11.1M
3
RNST icon
Renasant Corp
RNST
+$10.9M
4
AAPL icon
Apple
AAPL
+$9.67M
5
NCNO icon
nCino
NCNO
+$9.65M

Top Sells

Rank Stock Value
1
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$20.2M
2
TBBK icon
The Bancorp
TBBK
+$15.8M
3
AIZ icon
Assurant
AIZ
+$12.5M
4
NDSN icon
Nordson
NDSN
+$12.5M
5
VAC icon
Marriott Vacations Worldwide
VAC
+$12.4M

Sector Composition

Rank Sector Weight
1 Financials 20.06%
2 Industrials 18.84%
3 Healthcare 17.71%
4 Technology 13.16%
5 Consumer Discretionary 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESNT icon
651
Essent Group
ESNT
$6.08B
$328K 0.01%
5,104
– –
CRNT icon
652
Ceragon Networks
CRNT
$192M
$322K 0.01%
117,619
+15,563
+15% +$42.6K
HTO
653
H2O America
HTO
$2.56B
$319K 0.01%
5,483
– –
RBC icon
654
RBC Bearings
RBC
$17.6B
$318K 0.01%
1,062
– –
MTH icon
655
Meritage Homes
MTH
$4.69B
$316K 0.01%
3,082
– –
OPLN
656
Openlane
OPLN
$4.58B
$314K 0.01%
18,594
-6,089
-25% -$104K
SYBT icon
657
Stock Yards Bancorp
SYBT
$2.58B
$310K 0.01%
+5,000
New +$288K
PHM icon
658
Pultegroup
PHM
$24.8B
$301K 0.01%
2,099
– –
MMSI icon
659
Merit Medical Systems
MMSI
$5.36B
$279K 0.01%
+2,820
New +$258K
CYTK icon
660
Cytokinetics
CYTK
$10.8B
$277K 0.01%
5,251
+755
+17% +$42.1K
UEIC icon
661
Universal Electronics
UEIC
$71.6M
$277K 0.01%
29,987
+3,958
+15% +$39.9K
MGPI icon
662
MGP Ingredients
MGPI
$381M
$277K 0.01%
+3,323
New +$275K
NMFC icon
663
New Mountain Finance
NMFC
$726M
$259K 0.01%
21,628
– –
EPIX
664
DELISTED
ESSA Pharma
EPIX
$249K 0.01%
41,092
+6,627
+19% +$36.4K
UPLD icon
665
Upland Software
UPLD
$14.5M
$248K 0.01%
+9,949
New +$229K
CARG icon
666
CarGurus
CARG
$3.35B
$247K 0.01%
+8,241
New +$222K
NAMS icon
667
NewAmsterdam Pharma
NAMS
$3.34B
$233K 0.01%
14,046
+2,193
+19% +$37.9K
RCKT icon
668
Rocket Pharmaceuticals
RCKT
$397M
$219K ﹤0.01%
+11,843
New +$243K
TRMK icon
669
Trustmark
TRMK
$2.75B
$215K ﹤0.01%
6,768
-144,356
-96% -$4.64M
NTLA icon
670
Intellia Therapeutics
NTLA
$1.68B
$215K ﹤0.01%
+10,466
New +$241K
XEL icon
671
Xcel Energy
XEL
$48B
$208K ﹤0.01%
+3,190
New +$189K
ARCT icon
672
Arcturus Therapeutics
ARCT
$200M
$208K ﹤0.01%
+8,951
New +$191K
MET icon
673
MetLife
MET
$61.7B
$203K ﹤0.01%
+2,458
New +$184K
CRGY icon
674
Crescent Energy
CRGY
$4.03B
$191K ﹤0.01%
+17,472
New +$200K
CMPS
675
Compass Pathways
CMPS
$1.78B
$174K ﹤0.01%
27,679
+4,114
+17% +$29K
25 26
27
28 29

Similar funds

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return

Kennedy Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Kennedy Capital Management held 765 positions worth $4.53B, down 3.2% from $4.68B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Kennedy Capital Management withdrew a net $510M in Q3 2024, closing 78 positions and reducing 404 holdings. Its most notable exit was Silk Road Medical, Inc. Common Stock, an estimated $20.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Kennedy Capital Management opened a new position in Edwards Lifesciences worth $10.1M.

  • Kennedy Capital Management's largest Q3 2024 buy was Edwards Lifesciences: 153,046 shares worth $10.1M.
  • Kennedy Capital Management added most to Microsoft in Q3 2024, an estimated $11.4M increase.
  • Kennedy Capital Management's biggest Q3 2024 reduction was The Bancorp, cutting an estimated $15.8M.
  • Kennedy Capital Management fully exited Silk Road Medical, Inc. Common Stock in Q3 2024, selling an estimated $20.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.7% of its $4.53B portfolio in Q3 2024.
  • Kennedy Capital Management opened 71 new positions and closed 78 in Q3 2024.
  • Kennedy Capital Management's portfolio value fell 3.2% quarter-over-quarter to $4.53B.

Based on Kennedy Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.